AbCellera Biologics Inc. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 11.61M233.16M375.20M485.42M38.02M28.83M
Gross Profit 10.35M206.01M329.69M418.99M23.84M16.05M
Operating items
Depreciation & Amortization - Total 4.40M9.00M12.80M12.54M
Research & Development 10.11M29.39M62.06M107.88M175.66M167.26M
Selling, General & Administrative 2.75M11.91M41.85M55.48M61.00M72.71M
Other Operating Expenses -10.88M115.09M62.48M96.55M25.77M91.09M
Operating Expenses 15.73M77.12M170.79M268.91M275.23M343.60M
Operating Income -4.12M156.03M204.41M216.51M-237.21M-314.77M
EBIT -4.12M156.03M204.41M216.51M-237.21M-314.77M
Non-operating items
Interest & Investment Income 0.15M0.29M3.33M16.08M42.25M38.47M
Other Non Operating Income 1.77M8.32M17.49M10.55M14.15M62.28M
Non Operating Income 1.91M-6.81M14.74M22.59M63.18M114.37M
Net income details
EBT -2.21M163.08M219.15M239.10M-174.03M-200.40M
Tax Provisions 38.91M65.69M80.58M-27.63M-37.54M
Profit After Tax -2.21M118.92M153.46M158.52M-146.40M-162.86M
Income from Continuing Operations -2.21M124.16M153.46M158.52M-146.40M-162.86M
Consolidated Net Income -2.21M124.16M153.46M158.52M-146.40M-162.86M
Income towards Parent Company -2.21M124.16M153.46M158.52M-146.40M-162.86M
Net Income towards Common Stockholders -2.21M118.92M153.46M158.52M-146.40M-162.86M
Additional items
EPS (Basic) -0.00M0.00M0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M0.00M0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 265.95M265.95M281.58M286.10M290.17M295.37M
EBITDA -2.21M118.92M153.74M156.85M-146.73M-165.51M
Shares Outstanding 151.68M
Tax Rate 0.00M0.00M0.00M0.00M0.00M